Data Visualization

Out-of-Pocket Costs for Specialty Drugs in Medicare Part D

Out-of-Pocket Costs for Specialty Drugs in Medicare

Recent Work

View All
  • Drug Spending Glossary

    Drug spending is a complex issue that involves a range of products, policies, and stakeholders across the health care system. Understanding the many factors that affect drug spending is critical to grasping how pharmaceuticals are priced and purchased. These definitions provide a frame of reference when examining the drug spending debate. Read More

  • Pew Comments on Generic Drug Competition at FDA Public Meeting

    On Sept. 18, The Pew Charitable Trusts’ drug spending research initiative submitted comments to the Food and Drug Administration in response to its public meeting, “Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access.” Pew discussed ways to build on the success of the Drug Price Competition and Patent Term Restoration Act of 1984, or the... Read More

  • Policy Proposal: Reducing the Exclusivity Period for Biological Products

    Biological products, or biologics, are drugs made up of proteins or other materials derived from living cells through a complex manufacturing process. They are used to treat a wide range of health conditions, including cancer, rheumatoid arthritis, and multiple sclerosis, and are some of the most expensive drugs on the market, measured by both unit price and net contribution to spending. In 2015,... Read More

Media Contact

Erin Davis

Officer, Communications

202.540.6677